Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis

被引:29
作者
Brunkhorst, Frank [1 ]
Sakr, Yasser [1 ]
Hagel, Stefan [1 ]
Reinhart, Konrad [1 ]
机构
[1] Univ Jena, Dept Anesthesiol & Intens Care, D-07743 Jena, Germany
关键词
D O I
10.1097/01.anes.0000267531.39410.d3
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Background Characterizing the evolution of protein C concentrations in critically ill patients may help in identifying high risk groups and potential therapeutic targets. The authors investigated the time courses of protein C concentrations and their relation to the presence of sepsis, organ dysfunction/failure, mid outcome. Methods: This observational cohort study, in a university hospital surgical intensive care unit (ICU), included 312 consecutive patients with an estimated ICU length of stay more than 48 h. Plasma protein C concentrations and parameters of organ dysfunction were measured daily until discharge or death. Results: Protein C concentrations were below the lower limit of normal in 50.6% of patients (n = 158) on admission and decreased to a nadir within 3-4 days after admission before almost normalizing by 2 weeks thereafter, irrespective of the presence of sepsis, sex, source and type of admission, and type of surgery. The minimum protein C concentration was lower in patients with severe sepsis/septic shock (n = 54) than in those with sepsis (n = 63) and those who never had sepsis (n = 195), and was negatively correlated to the maximum Sequential Organ Failure Assessment score (R-2 = 0.345, P < 0.001). Protein C levels were lower in nonsurvivors (n = 46; 14.7%) than in survivors, especially in the first 4 days after admission. in a multivariable analysis with ICU mortality as the dependent variable, a minimum protein C concentration less than 45% was an independent risk factor for ICU death. Conclusions: in critically ill surgical patients, protein C concentrations were generally low, associated with organ dysfunction/failure. and independently associated with a higher risk of ICU mortality.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 31 条
[1]
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]
Changes of the hemostatic network in critically ill patients - Is there a difference between sepsis, trauma, and neurosurgery patients? [J].
Boldt, J ;
Papsdorf, M ;
Rothe, A ;
Kumle, B ;
Piper, S .
CRITICAL CARE MEDICINE, 2000, 28 (02) :445-450
[4]
AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure [J].
Dhainaut, JF ;
Shorr, AF ;
Macias, WL ;
Kollef, MJ ;
Levi, M ;
Reinhart, K ;
Nelson, DR .
CRITICAL CARE MEDICINE, 2005, 33 (02) :341-348
[6]
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation [J].
Dhainaut, JF ;
Yan, SB ;
Joyce, DE ;
Pettilä, V ;
Basson, B ;
Brandt, JT ;
Sundin, DP ;
Levi, M .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) :1924-1933
[7]
Esmon CT, 1999, HAEMATOLOGICA, V84, P254
[8]
The protein C pathway [J].
Esmon, CT .
CHEST, 2003, 124 (03) :26S-32S
[9]
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases [J].
Fisher, CJ ;
Yan, SB .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S49-S56
[10]
SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES [J].
FOURRIER, F ;
CHOPIN, C ;
GOUDEMAND, J ;
HENDRYCX, S ;
CARON, C ;
RIME, A ;
MAREY, A ;
LESTAVEL, P .
CHEST, 1992, 101 (03) :816-823